Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2025-12-29 @ 1:07 AM
Study NCT ID:
NCT05184335
Status:
RECRUITING
Last Update Posted:
2024-12-19
First Post:
2021-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Sponsor:
Reviva Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RVP-30-001 RECOVER
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None